(Q38455373)

English

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

scientific article published on September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

stem cell transplantation

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Bader P

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Hancock J

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Kreyenberg H

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Goulden NJ

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Niethammer D

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Oakhill A

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Handgretinger R

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Beck JF

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Klingebiel T

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1668-1672

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402552

0 references

Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of megadoses of purified haploidentical stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402552

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402552

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12200679%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38455373&oldid=1508830234"